OSF HealthCare Launches Clinical Trial for Nonrelapsing MS Patients
More than one million people in the United States live with Multiple Sclerosis (MS), a chronic neurological disease that affects the brain, spinal cord and nerves to the eyes. "It can present in a variety of ways like vision loss, double vision, weakness, or numbness on one side or both sides of the body,” says Tiffani Franada, DO, a neurologist with the OSF HealthCare Illinois Neurological Institute (INI) who specializes in the autoimmune disease. "Typically (multiple sclerosis) presents in young patients between 20 and 50 years of age. It's more common in women than men," Dr. Franada says. These events are called attacks or relapses, and they last a few weeks and then they get better. Patients can go awhile without anything, and then they can get other attacks down the line." The OSF HealthCare Illinois Neurological Institute has launched a clinical trial for patients with nonrelapsing secondary progressive MS (nrSPMS). Dr. Franada and her team are looking for further preventive
stLouIST